Hervycta 440Mg Inj

Question 1

How does Hervycta 440Mg Inj work?

Accepted Answer

Hervycta 440Mg Inj contains Trastuzumab, which works by inhibiting the excess production of a protein called human epidermal growth factor receptor 2 (HER2) in mammalian cells. This causes inhibition of the cancer cell growth.

Question 2

What are the points to be informed to the doctor before starting treatment?

Accepted Answer

Inform your doctor whether you have received any other cancer treatment. Hervycta 440Mg Inj may cause a decrease in left ventricular ejection fraction, cardiomyopathy, hypersensitivity reactions, pulmonary toxicity, and embryo-fetal toxicity during the treatment. Hence, inform your oncologist if you have any cardiovascular conditions, liver/kidney disease, lung problems, are pregnant, are planning to become pregnant, or are breastfeeding before receiving Hervycta 440Mg Inj.

Welcome User

Hervycta 440Mg Inj

Vivitra 440 Injection 1's

Neuzumab 440 mg Injection 20 ml

Trasturel 440 mg Injection 20 ml

Trumab 440 mg Infusion 1's

Eleftha 440 Injection 1's

Trazumab 440 Solution for Infusion 1's

Trasmab 440 mg Injection 1's

Herti 440 mg Injection 1's

Haltrust 440 Injection 1's

Hersima 440 mg Injection 20 ml

Priunta 440 Injection 20 ml

Herceptin 440 mg Injection 1's

Hermab 440 mg Injection 20 ml

Hervycta Plus 440Mg Injection

Ontramab 440 mg Injection 20 ml